About this trial

The investigators aim to develop a comprehensive patient registry of patients with non-CF bronchiectasis and/or Nontuberculosis Mycobacteria (NTM)

Eligibility criteria

Qualifiers

Over the age of 18

Non-CF Bronchiectasis

Nontuberculosis Mycobacteria (NTM)

Disqualifiers

Under the age of 18

CF bronchiectasis

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

2,000 Participants
are grouped into 2 trial groups

Locations

1
University of CalgaryT2N4N1, CalgaryAlberta, Canada

Sponsors and collaborators

University of Calgary

Lead sponsor

Insmed Incorporated

Collaborator

Trudell Medical International

Collaborator